| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2009PNAS..10616434M |
| P356 | DOI | 10.1073/PNAS.0905696106 |
| P932 | PMC publication ID | 2752572 |
| P698 | PubMed publication ID | 19805316 |
| P5875 | ResearchGate publication ID | 26871492 |
| P50 | author | Eric S. Tucker | Q37369786 |
| Thomas M. Maynard | Q37369807 | ||
| P2093 | author name string | Anthony-Samuel LaMantia | |
| Daniel W Meechan | |||
| P2860 | cites work | A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects | Q22008774 |
| Chromosome alignment and segregation regulated by ubiquitination of survivin | Q24297670 | ||
| T-brain-1: a homolog of Brachyury whose expression defines molecularly distinct domains within the cerebral cortex | Q24319264 | ||
| Genetic variation in the 22q11 locus and susceptibility to schizophrenia | Q24543969 | ||
| Isolation of the Cdc45/Mcm2-7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase | Q24548452 | ||
| HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression | Q24551005 | ||
| Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior | Q24671972 | ||
| The gene encoding proline dehydrogenase modulates sensorimotor gating in mice | Q28116128 | ||
| p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling | Q28117922 | ||
| Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice | Q28204189 | ||
| DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1 | Q28204282 | ||
| Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes | Q28251621 | ||
| Mitochondrial localization and function of a subset of 22q11 deletion syndrome candidate genes. | Q28293245 | ||
| The T-box transcription factor Eomes/Tbr2 regulates neurogenesis in the cortical subventricular zone | Q28507289 | ||
| TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome | Q28512803 | ||
| Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome | Q28587462 | ||
| Cortical inhibitory neurons and schizophrenia | Q29547683 | ||
| Cancer cell cycles | Q29547756 | ||
| Autism spectrum disorders: developmental disconnection syndromes | Q29616818 | ||
| Implications of normal brain development for the pathogenesis of schizophrenia | Q29618740 | ||
| Intermediate neuronal progenitors (basal progenitors) produce pyramidal-projection neurons for all layers of cerebral cortex | Q30490142 | ||
| Neuropathologic features in adults with 22q11.2 deletion syndrome. | Q31155517 | ||
| Mapping cortical thickness in children with 22q11.2 deletions | Q33644926 | ||
| A comprehensive analysis of 22q11 gene expression in the developing and adult brain | Q33717638 | ||
| Patterning centers, regulatory genes and extrinsic mechanisms controlling arealization of the neocortex | Q34115560 | ||
| GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis | Q34400922 | ||
| Altered cortical glutamate neurotransmission in schizophrenia: evidence from morphological studies of pyramidal neurons | Q35610994 | ||
| The Drosophila peanut gene is required for cytokinesis and encodes a protein similar to yeast putative bud neck filament proteins | Q36749820 | ||
| Role of intermediate progenitor cells in cerebral cortex development | Q37030395 | ||
| Site-specific regulation of cell cycle and DNA repair in post-mitotic GABA cells in schizophrenic versus bipolars | Q37245049 | ||
| Foxg1 haploinsufficiency reduces the population of cortical intermediate progenitor cells: effect of increased p21 expression | Q37465481 | ||
| Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model | Q38291113 | ||
| Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression | Q40018354 | ||
| RANBP1 localizes a subset of mitotic regulatory factors on spindle microtubules and regulates chromosome segregation in human cells. | Q40067121 | ||
| Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. | Q42070221 | ||
| Expression of the murine RanBP1 and Htf9-c genes is regulated from a shared bidirectional promoter during cell cycle progression | Q42660421 | ||
| The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects | Q43744085 | ||
| Expression of Cux-1 and Cux-2 in the subventricular zone and upper layers II-IV of the cerebral cortex | Q45081909 | ||
| Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate, or something else? | Q45989999 | ||
| Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome | Q46400538 | ||
| Molecular interaction between projection neuron precursors and invading interneurons via stromal-derived factor 1 (CXCL12)/CXCR4 signaling in the cortical subventricular zone/intermediate zone. | Q48331522 | ||
| Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome | Q48373444 | ||
| Architectonic map of neocortex of the normal mouse | Q48429551 | ||
| Congenital heart disease affects local gyrification in 22q11.2 deletion syndrome. | Q48631316 | ||
| Three distinct families of GABAergic neurons in rat visual cortex. | Q48699483 | ||
| Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. | Q50344711 | ||
| Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. | Q51909499 | ||
| Clinical features of 78 adults with 22q11 Deletion Syndrome. | Q51925287 | ||
| Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study. | Q52086051 | ||
| High rates of schizophrenia in adults with velo-cardio-facial syndrome. | Q52173679 | ||
| The development of parvalbumin-immunoreactivity in the neocortex of the mouse. | Q52214212 | ||
| Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) | Q62111746 | ||
| Emerging principles of altered neural circuitry in schizophrenia | Q73553170 | ||
| Abnormal patterns of cortical gyrification in velo-cardio-facial syndrome (deletion 22q11.2): an MRI study | Q82149730 | ||
| P433 | issue | 38 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurogenesis | Q1456827 |
| P304 | page(s) | 16434-16445 | |
| P577 | publication date | 2009-09-10 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome | |
| P478 | volume | 106 |
| Q36477668 | 22q11 Gene dosage establishes an adaptive range for sonic hedgehog and retinoic acid signaling during early development. |
| Q30478713 | 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia |
| Q34807703 | A Novel Stratification Method in Linkage Studies to Address Inter- and Intra-Family Heterogeneity in Autism |
| Q36451331 | A discovery resource of rare copy number variations in individuals with autism spectrum disorder |
| Q64111116 | Abnormal development of early auditory processing in 22q11.2 Deletion Syndrome |
| Q90315531 | Abnormalities in gray matter microstructure in young adults with 22q11.2 deletion syndrome |
| Q37384924 | Age, plasticity, and homeostasis in childhood brain disorders |
| Q40143999 | Altered neurobiological function of brainstem hypoglossal neurons in DiGeorge/22q11.2 Deletion Syndrome |
| Q92266786 | Altered white matter microstructure in 22q11.2 deletion syndrome: a multisite diffusion tensor imaging study |
| Q34294530 | Animal models of psychiatric disorders that reflect human copy number variation. |
| Q90091157 | Assessing auditory processing endophenotypes associated with Schizophrenia in individuals with 22q11.2 deletion syndrome |
| Q28298135 | Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications |
| Q36892242 | Association of IL-12p70 and IL-6:IL-10 ratio with autism-related behaviors in 22q11.2 deletion syndrome: a preliminary report |
| Q35539722 | Atypical developmental trajectory of functionally significant cortical areas in children with chromosome 22q11.2 deletion syndrome |
| Q36550431 | Atypical functional connectivity in resting-state networks of individuals with 22q11.2 deletion syndrome: associations with neurocognitive and psychiatric functioning |
| Q39353531 | Autism spectrum disorder: neuropathology and animal models |
| Q38104700 | Autism spectrum disorders: the quest for genetic syndromes |
| Q34206314 | Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models |
| Q30457809 | Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia |
| Q37412969 | Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome |
| Q30472917 | Bridging the gene-behavior divide through neuroimaging deletion syndromes: Velocardiofacial (22q11.2 Deletion) and Williams (7q11.23 Deletion) syndromes |
| Q38104759 | Cellular and molecular mechanisms controlling the migration of neocortical interneurons. |
| Q30432230 | Chronic ketamine produces altered distribution of parvalbumin-positive cells in the hippocampus of adult rats. |
| Q35423269 | Cognitive ability is associated with altered medial frontal cortical circuits in the LgDel mouse model of 22q11.2DS |
| Q35115389 | Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome |
| Q30458768 | Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders |
| Q37831223 | Copy number variants: a new molecular frontier in clinical psychiatry |
| Q48812094 | Cortical Development Requires Mesodermal Expression of Tbx1, a Gene Haploinsufficient in 22q11.2 Deletion Syndrome. |
| Q36187243 | Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome |
| Q43238247 | Cortical and Clonal Contribution of Tbr2 Expressing Progenitors in the Developing Mouse Brain. |
| Q33707853 | Cortical interneurons require Jnk1 to enter and navigate the developing cerebral cortex. |
| Q48405828 | Cortical-amygdala volumetric ratios predict onset of symptoms of psychosis in 22q11.2 deletion syndrome. |
| Q43742803 | Critical region within 22q11.2 linked to higher rate of autism spectrum disorder |
| Q36389564 | Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome. |
| Q34693662 | Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex |
| Q37255886 | Deficits in microRNA-mediated Cxcr4/Cxcl12 signaling in neurodevelopmental deficits in a 22q11 deletion syndrome mouse model |
| Q38237897 | Development of cortical interneurons |
| Q45738093 | Developmental excitatory-to-inhibitory GABA-polarity switch is disrupted in 22q11.2 deletion syndrome: a potential target for clinical therapeutics |
| Q37566124 | Dysphagia and disrupted cranial nerve development in a mouse model of DiGeorge (22q11) deletion syndrome |
| Q28509414 | Dysregulation of presynaptic calcium and synaptic plasticity in a mouse model of 22q11 deletion syndrome |
| Q35718069 | Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia |
| Q27692698 | From "directed differentiation" to "neuronal induction": modeling neuropsychiatric disease |
| Q24596191 | Functional impact of global rare copy number variation in autism spectrum disorders |
| Q39033511 | Gene-environment interactions in cortical interneuron development and dysfunction: A review of preclinical studies. |
| Q37228676 | Genetic contributions to changes of fiber tracts of ventral visual stream in 22q11.2 deletion syndrome |
| Q38110180 | Genetic models of schizophrenia and related psychotic disorders: progress and pitfalls across the methodological "minefield". |
| Q28390236 | Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis |
| Q64110346 | Impaired Interneuron Development in a Novel Model of Neonatal Brain Injury |
| Q64890460 | In the line-up: deleted genes associated with DiGeorge/22q11.2 deletion syndrome: are they all suspects? |
| Q34424435 | Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia |
| Q37596072 | Integrative mechanisms of oriented neuronal migration in the developing brain |
| Q36193399 | Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion |
| Q43524994 | Intrinsic Connectivity Network-Based Classification and Detection of Psychotic Symptoms in Youth With 22q11.2 Deletions |
| Q38064198 | Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia |
| Q89660970 | Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness |
| Q38715102 | MicroRNA-independent functions of DGCR8 are essential for neocortical development and TBR1 expression. |
| Q34714096 | Microstructural and functional connectivity in the developing preterm brain |
| Q28081179 | Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development |
| Q27691100 | Molecular mechanisms in 22q11 deletion syndrome |
| Q34855154 | Monoallelic deletion of the microRNA biogenesis gene Dgcr8 produces deficits in the development of excitatory synaptic transmission in the prefrontal cortex |
| Q55363878 | Mouse models of aneuploidy. |
| Q33629435 | Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophrenia |
| Q38143704 | Neural stem and progenitor cells in health and disease |
| Q34151425 | Neural stem cell regulation, fibroblast growth factors, and the developmental origins of neuropsychiatric disorders |
| Q26824953 | Neuronal migration abnormalities and its possible implications for schizophrenia |
| Q48661831 | Neuropathology of 22q11 deletion syndrome in an infant. |
| Q84693096 | Paraxial T-box genes, Tbx6 and Tbx1, are required for cranial chondrogenesis and myogenesis |
| Q39750431 | Performance on a computerized neurocognitive battery in 22q11.2 deletion syndrome: A comparison between US and Israeli cohorts |
| Q64988744 | Periventricular nodular heterotopia in 22q11.2 deletion and frontal lobe migration. |
| Q89820411 | Persistent Feeding and Swallowing Deficits in a Mouse Model of 22q11.2 Deletion Syndrome |
| Q34276729 | Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia |
| Q56232663 | Phenotypic variability of distal 22q11.2 copy number abnormalities |
| Q36496070 | Prenatal stress delays inhibitory neuron progenitor migration in the developing neocortex |
| Q39013176 | Prostaglandin E2 alters Wnt-dependent migration and proliferation in neuroectodermal stem cells: implications for autism spectrum disorders |
| Q36098844 | Ranbp1, Deleted in DiGeorge/22q11.2 Deletion Syndrome, is a Microcephaly Gene That Selectively Disrupts Layer 2/3 Cortical Projection Neuron Generation. |
| Q38616673 | Recurrent copy number variations as risk factors for neurodevelopmental disorders: critical overview and analysis of clinical implications |
| Q35031003 | Reduced transcript expression of genes affected by inherited and de novo CNVs in autism |
| Q36203393 | Selective overexpression of Comt in prefrontal cortex rescues schizophrenia-like phenotypes in a mouse model of 22q11 deletion syndrome. |
| Q42924998 | Structural abnormalities in cortical volume, thickness, and surface area in 22q11.2 microdeletion syndrome: Relationship with psychotic symptoms |
| Q37933422 | T-box factors: insights into the evolutionary emergence of the complex heart |
| Q37419966 | The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan. |
| Q30468033 | The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders |
| Q89040890 | The strengths of the genetic approach to understanding neural systems development and function: Ray Guillery's synthesis |
| Q34137368 | Three phases of DiGeorge/22q11 deletion syndrome pathogenesis during brain development: patterning, proliferation, and mitochondrial functions of 22q11 genes |
| Q89669003 | Transcriptional dysregulation in developing trigeminal sensory neurons in the LgDel mouse model of DiGeorge 22q11.2 Deletion Syndrome |
| Q38637625 | Using hiPSCs to model neuropsychiatric copy number variations (CNVs) has potential to reveal underlying disease mechanisms |
| Q37541142 | White matter abnormalities in 22q11.2 deletion syndrome: preliminary associations with the Nogo-66 receptor gene and symptoms of psychosis |
| Q37626841 | White matter microstructural abnormalities in girls with chromosome 22q11.2 deletion syndrome, Fragile X or Turner syndrome as evidenced by diffusion tensor imaging |
| Q34778177 | White matter microstructural abnormalities of the cingulum bundle in youths with 22q11.2 deletion syndrome: associations with medication, neuropsychological function, and prodromal symptoms of psychosis |
| Q37778420 | White matter neuron alterations in schizophrenia and related disorders |
| Q48729373 | miR-744 and miR-224 Downregulate Npas4 and Affect Lineage Differentiation Potential and Neurite Development During Neural Differentiation of Mouse Embryonic Stem Cells. |
Search more.